Organization
Monash University and Eastern Health
3 abstracts
Abstract
Adding mitomycin (MM) to bacillus Calmette-Guérin (BCG) as adjuvant intravesical therapy for high-risk, non–muscle-invasive urothelial bladder cancer (NMIBC): BCGMM; ANZUP 1301.Org: UWA Medical School, University of Western Australia & Linear Clinical Research, NHMRC Clinical Trials Centre, The University of Sydney, Fiona Stanley Hospital and Edith Cowan University,
Abstract
CLIMATE: Assessing the clinical utility of miR-371a-3p as a marker of residual disease in stage 1 testicular germ cell tumour (TGCT) following orchiectomy: ANZUP 1906.Org: Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Chris O'Brien Lifehouse, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, Princess Alexandra Hospital & University of Queensland,
Abstract
Association of common inherited NOD2 mutations with exceptional response to immune checkpoint inhibitors.Org: Garvan Institute of Medical Research, Darlinghurst, NSW, Australia, NHMRC Clinical Trials Centre, The University of Sydney, Princess Margaret Cancer Centre,